We are live on ! Find out more
DC

Defender Capital Portfolio holdings

AUM $308M
1-Year Est. Return 4.52%
This Fund
S&P 500
This Quarter Est. Return
+8.24%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
–
AUM
$280M
AUM Growth
+$50.6M
Cap. Flow
+$29.6M
Cap. Flow %
10.55%
Top 10 Hldgs %
86.06%
Holding
39
New
9
Increased
18
Reduced
7
Closed
1

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$8.97M
2
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$7.58M
3
COST icon
Costco
COST
+$7.53M
4
FTV icon
Fortive
FTV
+$5.3M
5
NUAN
Nuance Communications, Inc.
NUAN
+$4.53M

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$12.4M
2
MNST icon
Monster Beverage
MNST
+$3.86M
3
IGPT icon
Invesco AI and Next Gen Software ETF
IGPT
+$967K
4
AAPL icon
Apple
AAPL
+$394K
5
FIT
Fitbit, Inc. Class A common stock
FIT
+$136K

Sector Composition

Rank Sector Weight
1 Healthcare 35.62%
2 Technology 14.04%
3 Consumer Staples 13.77%
4 Financials 11.78%
5 Industrials 4.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CDMO
26
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$547K 0.2%
30,000
– –
IVV icon
27
iShares Core S&P 500 ETF
IVV
$876B
$468K 0.17%
1,176
+2
+0.2% +$774
DIS icon
28
Walt Disney
DIS
$165B
$388K 0.14%
2,105
+75
+4% +$13.8K
MSFT icon
29
Microsoft
MSFT
$2.84T
$364K 0.13%
1,543
-98
-6% -$22.7K
LFCR icon
30
Lifecore Biomedical
LFCR
$162M
$318K 0.11%
30,000
– –
VSAT icon
31
Viasat
VSAT
$9.79B
$288K 0.1%
+6,000
New +$291K
ITMR
32
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$287K 0.1%
+12,000
New +$285K
ARWR icon
33
Arrowhead Research
ARWR
$12.1B
$270K 0.1%
+4,000
New +$310K
KMI icon
34
Kinder Morgan
KMI
$73.1B
$250K 0.09%
+15,000
New +$229K
CSCO icon
35
Cisco
CSCO
$450B
$208K 0.07%
+4,016
New +$189K
STCN
36
DELISTED
Steel Connect, Inc. Common Stock
STCN
$113K 0.04%
6,107
+4,286
+235% +$70.5K
ATNX
37
DELISTED
Athenex, Inc. Common Stock
ATNX
$86K 0.03%
+1,000
New +$192K
SER icon
38
Serina Therapeutics
SER
$31M
$57K 0.02%
992
-43
-4% -$3.01K
FIT
39
DELISTED
Fitbit, Inc. Class A common stock
FIT
– –
-20,000
Closed -$136K
1
2

Similar funds

PC
Pecaut & Co Sioux City, Iowa $308M AUM 15.9% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
AC
Alfreton Capital Radlett, Hertfordshire, United Kingdom $308M AUM 10.23% 1-Year Est. Return
EWM
Elite Wealth Management Kirkland, Washington $308M AUM 30.88% 1-Year Est. Return
ICP
Islander Capital Partners San Francisco, California $308M AUM
ACM
Argyle Capital Management Center Valley, Pennsylvania $308M AUM 24.01% 1-Year Est. Return
BBWA
Bell & Brown Wealth Advisors Newport Beach, California $308M AUM 36.32% 1-Year Est. Return
ITB
Idaho Trust Bank Boise, Idaho $308M AUM 14.24% 1-Year Est. Return

Defender Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Defender Capital held 39 positions worth $280M, up 22% from $230M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Defender Capital deployed $29.6M of net new capital in Q1 2021, opening 9 new positions and adding to 18 existing holdings. Its largest new stake was Insight Molecular Diagnostics: 30,223 shares worth $3.12M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was STAAR Surgical, an estimated $12.4M trimmed.

  • Defender Capital's largest Q1 2021 buy was Insight Molecular Diagnostics: 30,223 shares worth $3.12M.
  • Defender Capital added most to Danaher in Q1 2021, an estimated $8.97M increase.
  • Defender Capital's biggest Q1 2021 reduction was STAAR Surgical, cutting an estimated $12.4M.
  • Defender Capital fully exited Fitbit, Inc. Class A common stock in Q1 2021, selling an estimated $136K.
  • Defender Capital's ten largest holdings make up 86% of its $280M portfolio in Q1 2021.
  • Defender Capital opened 9 new positions and closed 1 in Q1 2021.
  • Defender Capital's portfolio value rose 22% quarter-over-quarter to $280M.

Based on Defender Capital's 13F filing for Q1 2021, filed 20 Apr 2021.